FDMT
NASDAQ
$11.09
4D Molecular Therapeutics Inc (FDMT)
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $28.22 (+154.46%)
Market Cap
$611M
Revenue 5Y CAGR
+49.16%
Free Cash Flow Yield
-21.24%
Beta (5Y)
1.22
Price Chart
Valuation
Market Cap$611M
P/S6.92
P/B1.35
Profitability
Total Revenue (TTM)$88M
Gross Profit (TTM)-$129M
EBITDA-$175M
Profit Margin-182.3%
Operating Margin-2416%
EPS-$3.37
Financial Health
Free Cash Flow Yield-21.24%
Growth & Risk
Revenue 5Y CAGR+49.16%
FCF 5Y CAGR+19.39%
Beta (5Y)1.22
Sharpe Ratio1.41